Skip to content
Subscriber Only

Trade Tensions Have a Chinese Giant Rethinking U.S. Deals

  • Fosun to limit investments in U.S. biotech to small holdings
  • Trump’s Huawei ban adds to uncertainty over cross-border deals
Fosun Group Headquarters And Folli Follies Illustration As Fosun International Ltd. Shares Halted On Report Chairman Guo Guangchang Unreachable

Photographer: Qilai Shen/Bloomberg

Updated on

Sign up for Next China, a weekly email on where the nation stands now and where it's going next.

One of China’s most acquisitive companies is easing up on investments in the U.S., a sign the escalating trade fight is damping what has been a major source of M&A activity over the past five years.